Company news
Recce Pharmaceuticals Ltd. news in 2017
Recce Pharmaceuticals Ltd.'s news releases, calls and decks from 2017, newest first.
US FDA Grants Qualified Infectious Disease Product Designati
November 15, 2017
Appendix 4C - quarterly
October 31, 2017
Recce Launches Share Purchase Plan
September 27, 2017
Response to ASX Price Query
September 18, 2017
Recce Confirms Pre-IND Data Submission to US FDA
September 6, 2017
Appendix 4E and Financial Report
August 31, 2017
Recce Confirms Delivery by Intravenous Drip
July 30, 2017
Recce achieves milestone with volume production
July 19, 2017
Recce constructs automated manufacturing facility to support
June 22, 2017
Recce secures up to A$6.05 million investment agreement with
June 16, 2017
Recce moves closer to clinical study application
May 19, 2017
Operational Update
April 9, 2017
Data from large animal study shows RECCE 327 well tolerated
March 26, 2017
Appendix 4D and Interim Financial Statements
February 28, 2017
Microscopy Images of its Synthetic Antibiotic in Action Dest
February 23, 2017
Recce to suspend anti-cancer program
February 22, 2017
Operational Update and Quarterly Cash Flow
January 30, 2017
Lead compound reduces illness in mice infected by E.coli
January 17, 2017